The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized phase II study of everolimus (E), leuprolide + letrozole (LL), and E + LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC).
 
Ghassan K. Abou-Alfa
Consulting or Advisory Role - Aduro Biotech (I); Astellas Pharma; AstraZeneca (I); Celgene; Celsion; cipla; Exelixis; IntegraGen; Jennerex; Lilly/ImClone; MedImmune; Novartis; Pharmacyclics (I); Sanofi (I); Silenseed (I); Vicus Therapeutics
Research Funding - Abbott Laboratories (Inst); Amgen (Inst); Bayer (Inst); Exelixis (Inst); Genentech (Inst); Lilly/ImClone (Inst); Novartis (Inst); Polaris (Inst); Roche (Inst); Vicus Therapeutics (Inst)
Travel, Accommodations, Expenses - Polaris
 
Robert J. Mayer
Honoraria - Amgen; AstraZeneca
 
David Cosgrove
No Relationships to Disclose
 
Marinela Capanu
No Relationships to Disclose
 
Michael A. Choti
Consulting or Advisory Role - Bayer/Onyx
Research Funding - Bristol-Myers Squibb
 
Chloe Evelyn Atreya
Speakers' Bureau - Bayer
Research Funding - GlaxoSmithKline
 
Celina Ang
No Relationships to Disclose
 
Robin Kate Kelley
Consulting or Advisory Role - Acceleron Pharma; Exelixis (Inst); Lilly
Research Funding - Celgene (Inst); Exelixis (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Regeneron (Inst)
 
Richard Kinh Gian Do
No Relationships to Disclose
 
John Dozier Gordan
No Relationships to Disclose
 
Andrew X. Zhu
Consulting or Advisory Role - Eisai
 
Michele Ly
No Relationships to Disclose
 
Patrick Nolan
No Relationships to Disclose
 
Lakeisha Lubin
No Relationships to Disclose
 
James J. Harding
No Relationships to Disclose
 
Leonard Saltz
Consulting or Advisory Role - Abbott Biotherapeutics; Bayer; Boehringer Ingelheim; Lilly; pfizer; Roche/Genentech; Sun Pharma
Research Funding - Taiho Pharmaceutical
 
Alan P. Venook
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Lilly (Inst); Onyx (Inst)
Patents, Royalties, Other Intellectual Property - Royalties from Now-UptoDate for authoring and maintaining two chapters
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Genentech; Halozyme; Merck Serono; Roche